Stockreport

Wave Life Sciences Slips as Obesity Data Fails to Convince [Yahoo! Finance]

Wave Life Sciences Ltd. - Ordinary Shares  (WVE) 
Last wave life sciences ltd. - ordinary shares earnings: 3/2 06:45 am Check Earnings Report
PDF price targets to $21 and $13 respectively, citing insufficient data for WVE-007 as a standalone obesity treatment and reduced conviction in the liver Activin E knockdown [Read more]